Pharma & Biotech

Vericel Corporation (NASDAQ: VCEL) is facing a notable shift in investor sentiment, with significant institutional selling and a planned insider...

The acquisition of Iteos Therapeutics by Concentra Biosciences was formally completed on August 29, marking a significant corporate transition. Shareholders...

Eton Pharmaceuticals is reporting exceptional financial performance with quarterly revenue more than doubling and product demand surging dramatically. The company...

ANI Pharmaceuticals has delivered exceptional quarterly results and significantly raised its full-year guidance, propelled by unprecedented market adoption of its...

Adaptive Biotechnologies finds itself at a critical juncture, simultaneously celebrating exceptional financial performance while announcing the conclusion of a major...

Investors in Agios Pharmaceuticals are facing a tense waiting period as a crucial regulatory verdict approaches. The U.S. Food and...

With several critical investor conferences on the horizon, Zentalis Pharmaceuticals is making strategic moves to strengthen its team and align...

Organogenesis Holdings Inc. finds itself at a fascinating crossroads this week, caught between strong institutional confidence and a challenging quarterly...

Alx Oncology Holdings finds itself navigating contrasting currents as significant clinical advancements coincide with disappointing quarterly financial performance. The biopharma...

The coming days present two pivotal events for Anixa Biosciences that are likely to dictate the near-term trajectory of its...